New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
10:00 EDTVIVO, WIN, RDC, ESV, VRTX, BRY, SHW, RAH, REN, UTI, SDRL, FRED, TFM, CTLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CenturyLink (CTL) downgraded to Neutral from Overweight at Piper Jaffray... Ensco (ESV) downgraded to Hold from Buy at Deutsche Bank... Fred's (FRED) downgraded to Neutral from Buy at SunTrust... Ralcorp (RAH) downgraded to Neutral from Buy at UBS... Rowan Companies (RDC) downgraded to Hold from Buy at Deutsche Bank... Seadrill (SDRL) downgraded to Hold from Buy at Deutsche Bank... Sherwin-Williams (SHW) downgraded to Neutral from Buy at Nomura... Windstream (WIN) downgraded to Underweight from Neutral at Piper Jaffray... Universal Technical (UTI) downgraded to Underperform from Market Perform at BMO... Barry Petroleum (BRY) downgraded to Market Perform from Outperform at BMO Capital... Meridian Bioscience (VIVO) downgraded to Underperform from Neutral at Wedbush... Resolute Energy (REN) downgraded to Market Perform from Outperform at BMO Capital... Vertex (VRTX) downgraded to Hold from Buy at Argus... The Fresh Market (TFM) downgraded to Hold from Buy at Deutsche Bank.
News For CTL;ESV;FRED;RAH;RDC;SDRL;SHW;WIN;UTI;BRY;VIVO;REN;VRTX;TFM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 14, 2015
07:41 EDTRDCGlobal Hunter Securities to hold a conference
Subscribe for More Information
06:54 EDTTFMThe Fresh Market upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded The Fresh Market to Overweight with a $44 price target citing a favorable risk/reward following the recent pullback in shares.
06:13 EDTRENResolute Energy downgraded to Underweight from Equal Weight at Barclays
Subscribe for More Information
January 13, 2015
15:22 EDTVRTXVertex CEO says 'way too early' to talk about pricing for new CF combo drug
Vertex CEO Jeff Leiden speaking on CNBC.
10:00 EDTTFMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:20 EDTTFMThe Fresh Market downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded The Fresh Market to Neutral citing increased risks following the departure of CEO Craig Carlock.
07:36 EDTVRTXVertex price target raised to $146 from $125 at Piper Jaffray
Piper Jaffray raised its price target for Vertex Pharmaceuticals shares to $146 citing continued Kalydeco growth after the company issued 2015 guidance. Piper reiterates an Overweight rating on Vertex.
January 12, 2015
17:01 EDTFREDFred's names Michael Bloom COO
Subscribe for More Information
16:30 EDTTFMThe Fresh Market reaffirms FY14 EPS $1.56-$1.64, consensus $1.58
Subscribe for More Information
16:20 EDTTFMThe Fresh Market CEO Craig Carlock resigns, COO Sean Crane to succeed
The Fresh Market announced that the board appointed Sean Crane, executive VP and COO, as Interim CEO, effective immediately. Craig Carlock, president and CEO, and a member of the board, has left the company and has resigned as a member of the board. The company’s board has retained a national executive search firm to assist in identifying and evaluating candidates for the position of president and CEO.
13:14 EDTSDRLSeadrill volatility elevated as shares at six-year low
Seadrill January call option implied volatility is at 77, February is at 75, April is at 84; compared to its 26-week average of 45 according to Track Data, suggesting large near term price movement.
10:00 EDTSHWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTWINOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agnico-Eagle (AEM) upgraded at BMO Capital... Aimco (AIV) upgraded to Outperform from Market Perform at Wells Fargo... Alaska Air (ALK) upgraded at Evercore ISI... Alcoa (AA) upgraded to Buy from Neutral at Nomura... Alon USA Energy (ALJ) upgraded to Neutral from Sell at Goldman... AvalonBay (AVB) upgraded to Buy from Hold at Jefferies... BASF (BASFY) upgraded to Buy from Neutral at Citigroup... C.H. Robinson (CHRW) upgraded to Overweight from Equal Weight at Barclays... CBS (CBS) upgraded to Outperform at Cowen... Chesapeake (CHK) upgraded to Buy from Neutral at Goldman... China Mobile (CHL) upgraded to Buy from Hold at Jefferies... Chunghwa Telecom (CHT) upgraded to Neutral from Underweight at ... D.R. Horton (DHI) upgraded at KeyBanc... Daimler AG (DDAIF) upgraded to Neutral from Underperform at BofA/Merrill... Diamond Resorts (DRII) upgraded to Buy from Neutral at Goldman... FMC Corporation (FMC) upgraded to Buy from Neutral at BofA/Merrill... First Cash Financial (FCFS) upgraded to Buy from Neutral at Janney Capital... Frontier Communications (FTR) upgraded at BofA/Merrill... HomeAway (AWAY) upgraded to Outperform from Neutral at Macquarie... Ingersoll-Rand (IR) upgraded at Morgan Stanley... KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James... Knight Transportation (KNX) upgraded to Overweight from Equal Weight at Barclays... LabCorp (LH) upgraded to Outperform at RW Baird... M.D.C. Holdings (MDC) upgraded to Outperform from Market Perform at Raymond James... Mid-America Apartment (MAA) upgraded to Buy from Hold at Jefferies... PACCAR (PCAR) upgraded at RBC Capital... Parsley Energy (PE) upgraded to Neutral from Sell at Goldman... Peugeot (PUGOY) upgraded to Buy from Underperform at BofA/Merrill... Radware (RDWR) upgraded to Buy from Neutral at Buckingham... Rush Enterprises (RUSHA) upgraded at BB&T... Ryland Group (RYL) upgraded to Outperform from Market Perform at Raymond James... SL Green Realty (SLG) upgraded to Buy from Hold at Jefferies... Solera (SLH) upgraded to Buy from Neutral at Goldman... Standard Pacific (SPF) upgraded to Neutral from Underweight at JPMorgan... Statoil (STO) upgraded to Neutral from Sell at Goldman... Syngenta (SYT) upgraded to Buy from Hold at Miller Tabak... VMware (VMW) upgraded to Positive from Mixed at OTR Global... Vale (VALE) upgraded to Outperform from Sector Perform at Scotia Capital... Volvo (VOLVY) upgraded to Neutral from Underperform at BofA/Merrill... Windstream (WIN) upgraded at BofA/Merrill... lululemon (LULU) upgraded to Neutral from Underperform at Sterne Agee.
07:27 EDTWINWindstream upgraded at BofA/Merrill
Subscribe for More Information
06:22 EDTSHWSherwin-Williams downgraded to Neutral from Buy at UBS
Subscribe for More Information
06:01 EDTWINWindstream upgraded to Buy from Neutral at BofA/Merrill
January 11, 2015
21:04 EDTVRTXVertex expects Q4 Kalydeco revenue $460M
Subscribe for More Information
21:03 EDTVRTXVertex sees 2015 Kalydeco revenue $560M-$580M
Vertex expects that its combined non-GAAP R&D and SG&A expenses in 2015 will be in the range of $1.05B-$1.1B. It said the increase as compared to 2014 is primarily a result of launch preparation activities for lumacaftor in combination with ivacaftor and the planned pivotal Phase 3 development program for VX-661 in combination with ivacaftor. Vertex's expected non-GAAP R&D and SG&A expenses exclude stock-based compensation expense and certain other expenses recorded in 2015. Vertex said entered 2015 with approximately $1.4B in cash, cash equivalents and marketable securities. Anticipated 2015 Kalydeco net revenues reflect: Use of KALYDECO by eligible patients in Australia following the completion of reimbursement discussions in late 2014; Use of KALYDECO in people in the United States with the R117H mutation following FDA approval in late 2014; The completion of reimbursement discussions for gating mutations in certain European countries; Use of KALYDECO in children with CF ages 2 to 5 with the G551D or other gating mutations in the United States, based on potential approval in March 2015.
21:00 EDTVRTXVertex says NDA for combination of lumacaftor, ivacaftor accepted by FDA
Subscribe for More Information
20:57 EDTVRTXVertex says NDA for ivacaftor use in children accepted by FDA
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use